Assessing Arcellx (ACLX) Valuation After Recent Share Price Swings And Conflicting P/B And DCF Signals [Yahoo! Finance]
Arcellx, Inc. (ACLX)
Company Research
Source: Yahoo! Finance
Arcellx (ACLX) has been drawing attention after recent share price moves, with the stock up around 10% over the past month but showing a 21% decline over the past 3 months. See our latest analysis for Arcellx. At a share price of US$69.47, Arcellx has a 30 day share price return of 9.68% but a 90 day share price return of a 21.22% decline, while its 1 year total shareholder return of 7.27% and 3 year total shareholder return of 116.22% point to strong longer term momentum compared with recent weakness. If Arcellx's recent swings have your attention, this could be a good moment to see what else is moving in healthcare and biotech through healthcare stocks With Arcellx trading at US$69.47 against an analyst price target of US$112.35 and an intrinsic value estimate implying an 86% discount, you have to ask: is this a genuine opportunity, or is the market already factoring in future growth? On our data, Arcellx trades on a P/B of 9.1x, which is higher than both its biotech peer
Show less
Read more
Impact Snapshot
Event Time:
ACLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACLX alerts
High impacting Arcellx, Inc. news events
Weekly update
A roundup of the hottest topics
ACLX
News
- Arcellx (ACLX) Declined Despite Positive Clinical Trial Results [Yahoo! Finance]Yahoo! Finance
- Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $105.00 price target on the stock.MarketBeat
- Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $115.00 price target on the stock.MarketBeat
- Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain BinderBusiness Wire
- Is Arcellx (ACLX) Still Attractively Priced After Strong Multi Year Share Price Gains [Yahoo! Finance]Yahoo! Finance
ACLX
Earnings
- 11/5/25 - Miss
ACLX
Sec Filings
- 2/5/26 - Form SCHEDULE
- 1/20/26 - Form 4
- 1/20/26 - Form 144
- ACLX's page on the SEC website